Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms

Our News

SAN DIEGO, February 1, 2017 /PRNewswire/ -- ChemDiv Inc. to Conduct Medicinal Chemistry Studies on Compounds for Modulating Check Point NR2F6 Regen BioPharma Inc. (RGBP), (RGBPP) has entered into a Master Agreement with ChemDiv, Inc. to begin the ... Read More
See All News About Us >

Pharma News

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior ... Read More
See All Pharma News >

Featured Structures

Compound S511-0490 represents a new series of helix-mimetics possessing high drug-like and natural product-like properties.
This series is included in several of our new focused and special libraries.